Tetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer

Tetra Bio-Pharma Inc. today announced that it has entered into a collaboration agreement with Ovensa Inc. to evaluate TRIOZANTM, a proprietary nanomedicine platform for targeted delivery of cannabinoids to brain tumor cells.

Continue ReadingTetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer